Digitizing Drug Development: How much can it save?
The potential of data/ IT to transform drug development is a debate unfolding across healthcare and technology. Emerging cracks in…
Author
Choosing the right FDA ESG digital certificates
Aditya Anand, DGM - SAARC & ME, GMO GlobalSign, explains about the role of digital certificates and the process of acquiring…
Ganging up against Shigella bacteria
India is set to develop the world’s first Shigella vaccine, which is likely to hit the market by 2024. Will it prove to be the…
Building on strengths
Boehringer Ingelheim is undergoing a comprehensive transformation to derive more growth and value through strategic realignment of…
Pipeline drug offers promise in treatment of platinum-resistant ovarian cancer: GlobalData
ImmunoGen announced that the first patient was dosed in its pivotal Phase III study that investigates mirvetuximab soravtansine as…
Bladder cancer market size to more than triple to over $1.1 billion by 2025
The growth will be driven by the increased incorporation of immunotherapies into treatment algorithms, the launch of new…
Driving Innovation The NDDS Way
The need for a multidisciplinary approach to deliver greater therapeutic results has opened new avenues for growth in the novel…
Generating value in generics
Utkarsh Palnitkar, Partner and Head, Infrastructure, Government and Healthcare, Life Sciences, KPMG in India, gives an insight on…
IPM valued at Rs 9,225 crores in March 2017
Domestic companies continued to dominate the market with a 78 per cent share in March 2017